Peregrine Pharmaceuticals Inc. (MM) Stock Price - PPHM

Best deals to access real time data!
SMALL CAP BASIC
Monthly Subscription
for only
$29.03
ULTIMATE TRADER
Monthly Subscription
for only
$65.99
Big Cap Pro
Monthly Subscription
for only
$40.31
VAT not included
Company Name Stock Ticker Symbol Market Type ISIN Company Description
Peregrine Pharmaceuticals Inc. (MM) PPHM NASDAQ Common Stock US7136613046
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded DELAYED
  +0.0189 +6.17% 0.325 0.337 0.3075 0.337 0.3061 14:47:41
Bid Price Ask Price Spread Spread % News
0.325 0.3254 0.0004 0.12% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
787.00 954,272.00 $ 0.32 $ 305.19k 1.17M 0.29 - 1.31
Last Trade Time Type Quantity Stock Price Currency
14:48:50 100.00 $0.33 USD

Peregrine Pharmaceuticals Inc. (MM) Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 78.99M 242.38M $ -55.65M -0.28 0.00 213.9M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
967.61k $ 0.00 0.00% 111.83k 24.60%

more financials information »

Peregrine Pharmaceuticals Inc. (MM) News

Date Time Source News Article
12/06/201616:05GlobeNewswire Inc.Peregrine Pharmaceuticals Declares Quarterly Dividend on Its..
12/05/201616:05GlobeNewswire Inc.Peregrine to Report Financial Results for Second Quarter of..
11/14/201608:05GlobeNewswire Inc.New Study Demonstrates Anti-Tumor Advantages for Combination..
10/24/201608:05GlobeNewswire Inc.Preclinical Research Demonstrates Peregrine Pharmaceuticals’..
10/13/201616:45Edgar (US Regulatory)Form 8-K - Current report
10/12/201614:25Edgar (US Regulatory)Form 8-K - Current report
10/10/201608:05GlobeNewswire Inc.Peregrine Pharmaceuticals Reports Top-Line and Initial..

Historical PPHM Price Data

Period † Open High Low VWAP Min Vol Max Vol Avg. Daily Vol [m] Change %
1 Week0.3020.3370.29870.3051458k1M826k0.027.62%
1 Month0.30710.34790.29870.3110305k1M796k0.025.83%
3 Months0.38250.520.290.3724305k8M1M-0.06-15.03%
6 Months0.4980.520.290.3821302k8M1M-0.17-34.74%
1 Year1.201.310.290.5025302k16M1M-0.88-72.92%
3 Years1.243.180.291.3683036M1M-0.92-73.79%
5 Years0.99445.500.291.5507068M2M-0.67-67.32%

Peregrine Pharmaceuticals Inc. (MM) Description

Peregrine Pharmaceuticals, Inc. is a biopharmaceutical company developing first-in-class monoclonal antibodies for the treatment and diagnosis of cancer.
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:34 V: D:20161208 20:06:17